Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells

Melanoma is a drug-resistant cancer, representing a serious challenge in cancer treatment. Dacarbazine (DTIC) is the standard drug in metastatic melanoma treatment, despite the poor results. Hyperthermia has been proven to potentiate chemotherapy. Hence, this work analyzed the combined action of hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvador, Diana, Bastos, Verónica, Oliveira, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998307/
https://www.ncbi.nlm.nih.gov/pubmed/35408947
http://dx.doi.org/10.3390/ijms23073586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998307/
https://www.ncbi.nlm.nih.gov/pubmed/35408947
http://dx.doi.org/10.3390/ijms23073586

Ejemplares similares